Ge Jiang
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 10
-
- RNA Interference and Gene Delivery 7
- Protein purification and stability 6
- Bacillus and Francisella bacterial research 3
- Metabolomics and Mass Spectrometry Studies 1
- Co-authors
- Patrick P. DeLuca (9 shared papers)Sei Kwang Hahn (6 shared papers)Jiseok Kim (3 shared papers)Ki Su Kim (3 shared papers)Kitae Park (2 shared papers)Eun Ju Oh (3 shared papers)Byung Ho Woo (3 shared papers)Yeong Woo Jo (2 shared papers)
- Journals
- Pharmaceutical Research (5 papers)International Journal of Pharmaceutics (3 papers)International Journal of Biological Macromolecules (3 papers)Biopolymers (2 papers)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ge Jiang
44 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 99
- Pharmaceutical Science 584
- Biomaterials 366
- Molecular Medicine 188
- Molecular Biology 484
- Biomedical Engineering 267
Countries citing papers authored by Ge Jiang
This map shows the geographic impact of Ge Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Jiang more than expected).
Fields of papers citing papers by Ge Jiang
This network shows the impact of papers produced by Ge Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Jiang. The network helps show where Ge Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ge Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 155 | |
| 2 | 2001 | 144 | |
| 3 | 2008 | 140 | |
| 4 | 2004 | 137 | |
| 5 | 2002 | 132 | |
| 6 | 2007 | 95 | |
| 7 | 2017 | 88 | |
| 8 | 2002 | 87 | |
| 9 | 2001 | 80 | |
| 10 | 2003 | 79 | |
| 11 | 2002 | 72 | |
| 12 | 2005 | 72 | |
| 13 | 2003 | 70 | |
| 14 | 2008 | 65 | |
| 15 | 2007 | 43 | |
| 16 | 2007 | 35 | |
| 17 | 2022 | 31 | |
| 18 | Mechanistic studies of glass vial breakage for frozen formulations. I. Vial breakage caused by crystallizable excipient mannitol. | 2008 | 30 |
| 19 | 2008 | 29 | |
| 20 | 2009 | 29 |
About Ge Jiang
Ge Jiang is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Rehabilitation and Infectious Diseases, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (10 papers), RNA Interference and Gene Delivery (7 papers), Protein purification and stability (6 papers), Nanocomposite Films for Food Packaging (5 papers), Bacillus and Francisella bacterial research (3 papers), Wound Healing and Treatments (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Metabolomics and Mass Spectrometry Studies (1 paper). The work is most often cited by research in Pharmaceutical Science (584 citations), Biomaterials (366 citations), Molecular Medicine (188 citations), Molecular Biology (484 citations) and Biomedical Engineering (267 citations). Ge Jiang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Patrick P. DeLuca, Sei Kwang Hahn, Jiseok Kim, Ki Su Kim, Kitae Park, Eun Ju Oh, Byung Ho Woo, Yeong Woo Jo, B. C. Thanoo and Byung‐Soo Kim. Their work appears in journals such as Pharmaceutical Research, International Journal of Pharmaceutics, International Journal of Biological Macromolecules, Biopolymers and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.